trending Market Intelligence /marketintelligence/en/news-insights/trending/IXuVHKTIkZpswVAhLCQ9uw2 content esgSubNav
In This List

Avrobio CFO, chief medical officer to step down; replacement CFO named

Blog

Insight Weekly: M&A outlook; US community bank margins; green hydrogen players' EU expansion

Blog

Global M&A by the Numbers: Q2 2022

Blog

Insight Weekly: US bank M&A; low refinancing eases rates impact; Texas crypto mining booms

Blog

Infographic 2022 Top Tech Trends Shaping Corporations


Avrobio CFO, chief medical officer to step down; replacement CFO named

Avrobio Inc. said Katina Dorton and Nerissa Kreher are stepping down as CFO and chief medical officer of the company, respectively.

Erik Ostrowski will replace Dorton as CFO of the company, effective January 2019. Ostrowski was previously CFO of Summit Therapeutics PLC.

Meanwhile, Kreher will continue as a clinical adviser to Avrobio in a transitional role during the first quarter of 2019.

Cambridge, Mass.-based Avrobio develops gene therapies for treating rare diseases.